Forecasts data is unavailable for this security.
Consensus recommendation
- 20-Feb-25
- 20-Nov-25
- 18-Dec-25
- 15-Jan-26
- 05-Feb-26
Select bar for recommendation details.
| Recommendations | 05-Feb-26 | |
|---|---|---|
| Buy | 0 | |
| Outperform | 5 | |
| Hold | 0 | |
| Sell | 0 | |
| Strong Sell | 0 |
Share price forecast in AUD
The 5 analysts offering 12 month price targets for PYC Therapeutics Ltd have a median target of 3.88, with a high estimate of 4.96 and a low estimate of 2.25. The median estimate represents a 159.53% increase from the last price of 1.50.
| High | 231.8% | 4.96 |
| Med | 159.5% | 3.88 |
| Low | 50.2% | 2.25 |
Earnings history & estimates in AUD
| Average growth rate | -545.04% |
More ▼
Revenue history & estimates in AUD
| Average growth rate | +489.02% |
More ▼
